| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |